The attitude of patients towards antipsychotic depot treatment

International Clinical Psychopharmacology

Volumn 22, Issue 5, 2007, Pages 275-282

  Heres, Stephan ^a   Schmitz, Florian Simon ^b   Leucht, Stefan ^a   Pajonk, Frank Gerald ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Acceptance; Antipsychotic; Depot; Patient attitude; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; SCHIZOPHRENIA; TREATMENT INDICATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LONG-TERM CARE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 34547785173     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3280c28424     Document Type: Article

References (17)

1. Davis JM, Matalon L, Watanabe MD, Blake L, Metalon L (1994). Depot antipsychotic drugs: place in therapy. Drugs 47:741-773.
2. Dolder CR, Lacro JP, Dunn LB, Jeste DV (2002). Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 159:103-108.
3. Eastwood N, Pugh R (1997). Long-term medication in depot clinics and patients' rights: issue for assertive outreach. Psychiatric Bull 21:173-175.
4. Fleischhacker WW, Eerdekens M, Karcher K, Remington G, Llorca PM, Chrzanowski W, et al. (2003). Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic. J Clin Psychiatry 64:1250-1257.
5. Fleischhacker WW, Rabinowitz J, Kemmler G, Eerdekens M, Mehnert A (2005). Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. Br J Psychiatry 187:131-136.
6. Gitlin M, Nuechterlein K, Subotnik KL, Ventura J, Mintz J, Fogelson DL, et al. (2001). Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry 158:1835-1842.
7. Hamann J, Pfeiffer H, Leucht S, Kissling W (2003). Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists. Pharmacopsychiatry 36:309-312.
8. Heres S, Hamann J, Kissling W, Leucht S (2006). Attitudes of psychiatrists towards antipsychotic depot medication. J Clin Psychiatry 67:1948-1953.
9. Hoenkamp E, Knegtering H, Hooy JJS, van der Molen AEGM (1995). Patient requests and attitude towards neuroleptics. Nord J Psychiatry 49:47-55.
10. Irani F, Dankert M, Brensinger C, Bilker WB, Nair SR, Kohler CG, et al. (2004). Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology 29:960-968.
11. Lam YW, Velligan DI, Dicocco M, Ereshefsky L, Maples NJ, Castillo DA, et al. (2003). Comparative assessment of antipsychotic adherence by concentration monitoring, pill count and self report. Schizophr Res 60 (Suppl.):313.
12. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223.
13. Möller HJ, Llorca PM, Sacchetti E, Martin SD, Medori R, Parellada E (2005). Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies. Int Clin Psychopharmacol 20:121-130.
14. Pereira S, Pinto R (1997). A survey of the attitudes of chronic psychiatric patients living in the community toward their medication. Acta Psychiatr Scand 95:464-468.
15. Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, et al. (2004). Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 30:255-264.
16. Walburn J, Gray R, Gournay K, Quraishi S, David AS (2001). Systematic view of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry 179:300-307.
17. Wistedt B (1995). How does the psychiatric patient feel about depot treatment, compulsion or help. Nord J Psychiatry 49:41-46.